PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
1.01M
Worse than TGTX's estimated revenue of 4.27M.
-202.40K
Better than TGTX's estimated ebitda of -3.32M.
-1.35
Worse than TGTX's estimated eps of -1.34.
-35.97M
Better than TGTX's estimated net income of -199.66M.
-202.40K
Better than TGTX's estimated ebit of -3.32M.
37.50M
Better than TGTX's estimated sg&a expense of 846.41M.
Analyze DCF forecasts for the company and compare them with competitors.
1.03M
Worse than TGTX's revenue of 2.79M.
-9.97%
Better than TGTX's revenue growth rate of -58.36%.
-33.41M
Better than TGTX's ebitda of -187.63M.
-3243.20%
Better than TGTX's ebitda margin of -6737.13%.
-34.10M
Better than TGTX's ebit of -188.14M.
-3311.07%
Better than TGTX's ebit margin of -6755.62%.
699.00K
Worse than TGTX's depreciation of 515.00K.
108.91M
Worse than TGTX's total cash of 174.08M.
10573.79%
Better than TGTX's cash as percentage of revenue of 6250.70%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
10.13M
Better than TGTX's accounts payable of 42.02M.
983.50%
Better than TGTX's payables as percentage of revenue of 1508.76%.
-366.00K
Better than TGTX's capital expenditure of -14.00K.
-35.53%
Better than TGTX's capex as percentage of revenue of -0.50%.
4.99%
Better than TGTX's weighted average cost of capital (wacc) of 14.67%.
5.02%
Better than TGTX's cost of equity of 14.75%.
4.08%
Better than TGTX's cost of debt of 11.39%.
-0.23
Better than TGTX's beta of 2.19.
30.07M
Better than TGTX's diluted shares outstanding of 148.51M.
1.57M
Better than TGTX's total debt of 110.80M.
49.31M
Worse than TGTX's total equity of 4.61B.
50.89M
Worse than TGTX's total capital of 4.72B.
3.09%
Worse than TGTX's debt weighting of 2.35%.
96.91%
Worse than TGTX's equity weighting of 97.65%.
-32.98M
Better than TGTX's ebiat of -193.36M.
-28.05M
Better than TGTX's unlevered free cash flow of -173.05M.
2.00%
Equal to TGTX's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than TGTX's net debt of 17.86M.
71.33M
Better than TGTX's equity value of -3.10B.
2.37
Better than TGTX's equity value per share of -20.88.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.